A Functional Assessment Tool to Distinguish Controls From Alzheimer’s Disease in Lima, Peru
- Nilton Custodio(corresponding author),
- Rosa Montesinos,
- ,
- Eder Herrera-Perez,
- Maritza Pintado-Caipa,
- Wendy Seminario G
- Universidad Privada San Juan Bautista,
- Instituto Peruano de Neurociencias,
- ,
- Universidad San Ignacio de Loyola,
- University of California, San Francisco,
- Universidad Privada del Norte
Open access
Publication Information
Output type
Original language
EnglishJournal (Volume, Issue Number)
American Journal of Alzheimer's Disease and other Dementias (Volume 37)Publication milestones
- Published - 05/2022
Publication status
ISSN
1533-3175Publication IDs
- Scopus: 85131337544
- PubMed: 35656899
Abstract
Background: The Alzheimer’s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale is a versatile functional assessment tool for patients with Alzheimer’s disease (ad). We evaluated its performance in controls, Peruvians with MCI or AD. Methods: A cross-sectional study of older adults attending a neurology institute in Lima (Peru) with mild cognitive impairment (MCI), ad or cognitively healthy. Test-retest reliability (intraclass correlation coefficient, ICC; internal consistency, Cronbach’s alpha) and validity were assessed. Results: We enrolled 276 individuals (ad: 113, MCI: 68, controls: 95) with no age, sex, educational level, and depressive symptom differences. Reliability was ideal (ICC:.996), and Cronbach’s alpha was adequate (.937). The ADCS-ADL could not differentiate MCI from controls but did differentiate ad severity. The ADCS-ADL correlated highly with nearly all tools. Conclusions: The ADCS-ADL scale is reliable in a population with ad in Lima, Peru. Future work may validate a tool for Peruvians with lower educational levels.
Access to documents
Publication metrics
Metrics
Sustainable Development Goals
- SDG 3 Good Health and Well
